Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Met all endpoints in Phase 3 pivotal study for Anaphylm™ (epinephrine) Sublingual Film in first quarter 2024 when compared to EpiPen® and other injectors used for the treatment of anaphylaxis On track to complete Anaphylm temperature/pH study in second …